The board of directors of Glenmark Pharmaceuticals Limited (NSEI:GLENMARK) approved the sale of a 7.84% stake or 9,609,571 equity shares, in Glenmark Life Sciences Limited (NSEI:GLS), as stated in its filing to the exchanges on 10 July 2024. The stake sale will be done through the stock exchanges via an offer for sale (OFS). The decision was made at a meeting held on 10 July 2024, and the company informed about the development aftermarket hours.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
855.1 INR | +1.17% |
|
-3.53% | +30.14% |
11/07 | Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences | MT |
10/07 | Glenmark Pharma to Sell 7.84% Stake in Glenmark Life via Offer for Sale | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,411 INR | +0.18% | +4.01% | 475.5Cr | ||
855.1 INR | +1.17% | -3.53% | 123.93Cr | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.14% | 123.93Cr | |
+61.62% | 86TCr | |
+38.95% | 63TCr | |
-3.89% | 36TCr | |
+15.41% | 32TCr | |
+9.08% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+16.05% | 18TCr | |
+2.17% | 16TCr |
- Stock Market
- Equities
- GLS Stock
- News Glenmark Life Sciences Limited
- Glenmark Pharma to Sell 7.84% Stake in Glenmark Life via Offer for Sale